You are here

Article info

Article menu
Basic tumor immunology
Original research
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses

Authors

  • Shuai Zhang Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceDepartment of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaFaculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Liwei Zhao Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France PubMed articlesGoogle scholar articles
  • Mengfei Guo Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Peng Liu Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France PubMed articlesGoogle scholar articles
  • Sijing Li Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceFaculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Wei Xie Cell death and Inflammation Unit, VIB-UGent Center for Inflammation Research, Ghent, BelgiumDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Ai-Ling Tian Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France PubMed articlesGoogle scholar articles
  • Jonathan G Pol Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France PubMed articlesGoogle scholar articles
  • Hui Chen Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceFaculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Hui Pan Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceFaculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Misha Mao Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceFaculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, FranceSurgical Oncology Department, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China PubMed articlesGoogle scholar articles
  • Yumei Li Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Laurence Zitvogel INSERM U1015, Equipe labellisée par la Ligue contre le cancer, Gustave Roussy, Villjuif, FranceClinicObiome, Gustave-Roussy, Villejuif, France PubMed articlesGoogle scholar articles
  • Yang Jin Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Oliver Kepp Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France PubMed articlesGoogle scholar articles
  • Guido Kroemer Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, FranceCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, FranceInstitut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France PubMed articlesGoogle scholar articles

Citation

Zhang S, Zhao L, Guo M, et al
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Journal for ImmunoTherapy of Cancer 2023;11:e006785. doi: 10.1136/jitc-2023-006785
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.